BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

PATHWAY GENOMICS CORPORATION — Lobbying — Receipts Report

LD-2 disclosure · 3rd Quarter - Report

PATHWAY GENOMICS CORPORATION

via LEGISLATIVE STRATEGIES CA

3rd Quarter (July 1 - Sep 30) · 2013Posted Oct 22, 2013Filing document ↗LDA record ↗

Income$15Kfee reported

Client

Name: PATHWAY GENOMICS CORPORATION
Description: Genetic testing
Location: California · United States of America

Registrant

Firm: LEGISLATIVE STRATEGIES CA
Description: Consulting and lobbying
Location: Bonita, California, United States of America

Lobbying activities

1 issue

Health Issues
Healthcare reform
LobbyistsMITCH MULANIX
TargetedSENATE · HOUSE OF REPRESENTATIVES

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.